Fluid Flow Optimization Systems for Industrial Processes
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of implantable intraluminal devices to optimize fluid flow in various industrial processes, enhancing efficiency and reducing costs.
Background and Problem Solved
The original patent addressed implantable medical devices for bodily cavities, organs, and vessels. However, industrial processes, such as chemical plants, oil wells, and HVAC systems, face distinct fluid flow challenges. Current solutions often result in clogging, pressure drops, and inefficient flow rates. This inventive concept adapts the stent graft technology to tackle these specific problems, providing a novel solution for industrial fluid flow optimization.
Detailed Description of the Inventive Concept
The inventive concept involves deploying stent graft devices in industrial pipelines, ducts, or wells. Each device features multiple tubular segments, each with an individual annular stent member and a tubular membrane. At least one flow channel is disposed at the peripheral wall of the stent graft device, enabling fluid communication and flow control. The system can be configured to monitor and control fluid flow, optimize flow rates, and reduce pressure drops. In oil wells, the system prevents clogging, while in HVAC systems, it reduces pressure drop and improves efficiency.
Novelty and Inventive Step
The inventive concept's novelty lies in its application of stent graft technology to industrial fluid flow optimization, addressing a previously unexplored field. The inventive step resides in the adaptation of the original patent's design to accommodate the unique demands of industrial processes, such as high-pressure and high-flow rate environments.
Alternative Embodiments and Variations
Alternative embodiments may include using different materials for the stent graft device, varying the number and configuration of tubular segments, or integrating sensors and actuators for real-time flow control. Variations could also involve applying this technology to other industrial processes, such as water treatment or food processing.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including chemical processing, oil and gas, HVAC, and agriculture. By optimizing fluid flow, companies can reduce energy consumption, increase efficiency, and minimize downtime. The market for industrial fluid flow optimization solutions is substantial, with potential applications in new installations, retrofits, and aftermarket services.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/07 |
| A | A61 | A61F2/04 |
| A | A61 | A61F2/852 |
| A | A61 | A61F2/88 |
| A | A61 | A61F2/89 |
| A | A61 | A61F2002/041 |
| A | A61 | A61F2002/075 |
| A | A61 | A61F2240/001 |
| A | A61 | A61F2250/0065 |
| Y | Y10 | Y10T29/49826 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering and biomedical fluid flow systems, with expertise in implantable tubular devices, stent graft technologies, and fluid management across medical and industrial applications
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, knowledge of materials science, fluid dynamics, and experience in designing implantable medical devices with complex geometrical configurations
Obviousness Rationale
A PHOSITA would recognize that the fundamental structural principles of the source patent's stent graft device - helically arranged membranous strips, fluid flow channels, and modular tubular configurations - are directly transferable to industrial fluid management contexts. The core technological innovation of creating controlled fluid pathways through strategic membrane and support member design is universally applicable across medical and industrial domains. The PTD merely extends the source patent's core mechanical principles to alternative implementation environments.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,407 |
|---|---|
| Title | Implantable intraluminal device |
| Assignee(s) | W. L. Gore & Associates, Inc. |